2.27
price down icon8.28%   -0.205
after-market Handel nachbörslich: 2.27
loading

Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
34.57%
65.42
48.61 61.20 43.52 94.97
Operating Income/Loss
34.57%
-65.42
-48.61 -61.20 -43.52 -94.97
Net Income/Loss
34.79%
-63.63
-47.21 -58.83 -42.15 -93.80
Basic Average Shares
6.79%
295.67
276.86 7.654 260.49 238.41
Diluted Average Shares
6.79%
295.67
276.86 7.654 260.49 238.41
Basic Earnings Per Share
29.41%
-0.22
-0.17 -0.21 -0.16 -0.39
Diluted Earnings Per Share
29.41%
-0.22
-0.17 -0.21 -0.16 -0.39
$1.52
price down icon 7.88%
$12.14
price down icon 5.67%
DNA DNA
$10.27
price down icon 12.67%
$4.59
price down icon 2.96%
IVA IVA
$2.94
price down icon 5.47%
$9.36
price down icon 2.80%
Kapitalisierung:     |  Volumen (24h):